Back to top

CRVS forms 200 Day Moving Average Support on July 29

Corvus Pharmaceuticals, Inc. (CRVS) — Nightly Technical Analysis · Jul 30, 2026, 02:12 ET
On Wednesday, July 29th, CRVS moved down 2.03% while volume shrunk to 0.5× the usual levels. Mixed technical signals appeared with 200 DMA Support suggesting upside potential, while Fell Below 50 DMA indicated possible weakness — creating a conflicted technical picture. Key support levels exist at 12.72, 12.41 & 12.02, with resistance at 13.42, 13.81 & 14.12. Slow Stochastic readings suggest the stock is currently oversold.

Current SwingTradeBot Technical Rating of CRVS: C

What else did CRVS do today? Find out on SwingTradeBot.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Corvus Pharmaceuticals, Inc. (CRVS)